Central diabetes insipidus: a late sequela of BNT162b2 SARS-CoV-2 mRNA vaccine?

BACKGROUND: The development of an effective vaccine is a powerful tool to contain the global spread of coronavirus disease 2019 (COVID-19). Still, it raises potential safety concerns about the subsequent enhancement of associated immunopathology. Increasing evidence shows that the endocrine system,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishay, Avraham, Shacham, Elena Chertok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945387/
https://www.ncbi.nlm.nih.gov/pubmed/36810011
http://dx.doi.org/10.1186/s12902-023-01296-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945387/
https://www.ncbi.nlm.nih.gov/pubmed/36810011
http://dx.doi.org/10.1186/s12902-023-01296-4

Ejemplares similares